Clinical Report: Distinct Clinical Domains in Axial Spondyloarthritis Revealed

Overview

This study evaluates the determinants of patient and physician global assessments in axial spondyloarthritis (axSpA).

Background

Axial spondyloarthritis is a complex inflammatory condition that affects multiple aspects of patients' lives, including physical, psychological, and social dimensions. Accurate assessment of disease activity is crucial for effective management and treatment planning.

Data Highlights

No numerical data or trial data was provided in the source material.

Key Findings

• Patient global assessment (PtGA) reflects subjective symptom burden and psychological factors.
• Physician global assessment (PhGA) is more closely linked to objective structural or inflammatory parameters.
• Discordance between PtGA and PhGA may indicate distinct clinical domains rather than measurement disagreement.
• The study included 155 patients fulfilling the modified New York criteria for axSpA.
• Both assessments are integral components of disease evaluation in axSpA.

Clinical Implications

Clarifying the distinct drivers of PtGA and PhGA can inform clinical decision-making.

Conclusion

The study emphasizes the importance of recognizing the different clinical domains captured by PtGA and PhGA in axial spondyloarthritis.

Related Resources & Content

1. Clinical Rheumatology, 2026 -- Discrepancies in the assessment of axial spondyloarthritis between patients and rheumatologists: what does this mean?
2. Journal of Medical Internet Research (JMIR), 2026 -- Facilitators and Barriers to Implementing a Remote Monitoring Model of Care for Stable Patients With Axial Spondyloarthritis Using the Consolidated Framework for Implementation Research: Qualitative Study
3. Frontiers in Medicine, 2026 -- Differences in clinical features between axial psoriatic arthritis and axial spondyloarthritis: a systematic review and meta-analysis of observational studies
4. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update
5. Upadacitinib for axial spondyloarthritis: a meta-analysis of efficacy and safety - PubMed
6. Clinical Rheumatology — Exploring Gender Variations in the Diagnostic Pathway and Outcomes of Axial Spondyloarthritis: Findings from the European Map of Axial Spondyloarthritis (EMAS)
7. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update
8. Upadacitinib for axial spondyloarthritis: a meta-analysis of efficacy and safety - PubMed
9. Patient-physician discordance in global assessment in early spondyloarthritis and its change over time: the DESIR cohort - ScienceDirect